Search results
Fox Point teen diagnosed with leukemia gets wish fulfilled with local 'Amazing Race'
WISN 12 Milwaukee· 5 days agoMake-A-Wish Wisconsin helped a Fox Point teen's wish come true with a Milwaukee version of "The...
Is Geron Stock a Buy Following Its First New Drug Approval?
Motley Fool via Yahoo Finance· 6 days agoThe condition affects about 60,000 Americans, with roughly 16,000 new reported cases annually....
Kura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of “Moderate Buy” by Analysts
ETF DAILY NEWS· 1 day agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat Ratings reports ...
Report Shows Harmful Gas Leaks Aren't Detectable by Smell. Here's What We Know
CNET· 4 days agoAnother alarming study has been published calling into question the safety of natural gas. The...
New cancer treatment increases efficacy by injecting chemo directly into tumor cells
BGR· 5 days agoChemotherapy has proven to be a fairly successful treatment for cancer. The Food and Drug...
StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
ETF DAILY NEWS· 1 day agoInvestment analysts at StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “sell” rating ...
Vinva Investment Management Ltd Sells 681 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
ETF DAILY NEWS· 5 days agoVinva Investment Management Ltd lessened its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 28.6% in the fourth quarter, HoldingsChannel.com reports. The fund ...
BeiGene, Ltd. (NASDAQ:BGNE) Receives $251.93 Average PT from Brokerages
ETF DAILY NEWS· 3 days agoBeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has received an average rating of “Moderate Buy” from the ten analysts that are covering the firm, Marketbeat reports. Two research analysts have ...
The Big Climb
The Bradford Era· 7 days agoAs a geezer who can barely make it up the dozen steps in my house without getting winded, I never thought I would make it up and down 2,500 steps
GENMAB A/S/S (OTCMKTS:GMXAY) and LianBio (NASDAQ:LIAN) Critical Contrast
ETF DAILY NEWS· 3 days agoLianBio (NASDAQ:LIAN – Get Free Report) and GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses ...